Molecular Cytogenetics Market to expand at an 8.9% value CAGR by 2032 | Says FMI Analyst

With a forecasted CAGR of 8.9% from 2022 to 2032, the global Molecular Cytogenetics Market demand is expected to be worth US$ 2,761.9 million in 2022. The development is attributed to evolving approaches to disease diagnosis, growing public awareness of viral diseases, and rising levels of government funding in various jurisdictions. The enterprise key management market experienced a CAGR of 10.3% from 2016 to 2021.

Molecular cytogenetics comprises of molecular biology and cytogenetics. Cytogenetics refers to the study of chromosomes and molecular cytogenetics further involves the analysis of genetic variations or alterations through in-situ hybridization techniques. Molecular cytogenetics finds crucial applications in the fields of biology and medicine.

Molecular cytogenetics studies the structural and functional organization of the chromosomes and its nucleus, genomic variations, expression and evolution, chromosomal abnormalities, particularly in medicinal and cancer-related genetics.

Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2031

In molecular cytogenetics, techniques such as fluorescence in situ hybridization (FISH) are conducted wherein DNA probes are labeled with different colored fluorescent tags to visualize the whole genome or the most specific regions of the genome. Also, the virtual karyotyping technique is done in molecular cytogenetics to assess entire genome for the changes in the number of copies of the genome. FISH & GISH are one of the most reliable techniques for analyzing chromosomes.

Global Molecular Cytogenetics Market: Drivers and Restraints

Molecular cytogenetics provides a scan and analysis of the whole genome organization, its structure and behavior at high resolutions and also the visualization of single peculiar genomic loci which is a major growth driver for the global molecular cytogenetics market. The recent advances in the fields of molecular biology and cytogenetics have brought about several key developments in the research of mitosis and meiosis processes, chromosome structures and its subsequent manipulation, gene expression and its regulation, and gene silencing techniques. Molecular cytogenetics is primarily driven by cancer diagnostics which offers techniques for imaging in genetics, epigenetics, and cytology and can be utilized for chromosomal modifications.

Ask the Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-2031

Global Molecular Cytogenetics Market: Regional Outlook

Geographically, the global molecular cytogenetics market is segmented into seven regions, namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America & Western Europe are market leaders regarding revenue in the global molecular cytogenetics market owing to the presence of large number of clinical research laboratories and research & academic institutes. Japan is the third major contributor to the global molecular cytogenetics market mainly due to the well-established collaborations between the manufacturers and research laboratories. Also, the role of personalized medicine in treatment of genetic or other disorders is gaining pace in the developed countries and this factor is anticipated to unfold novel opportunities for the key players during the forecast period. APEJ is anticipated to register healthy CAGR in the global molecular cytogenetics market due to a surge in the number of scientific researches being undertaken in this region. Middle East and Africa and Latin America are at nascent stages in the global molecular cytogenetics market and are projected to register steady growth rates during the forecast period.

Key Companies Profiled:

• Thermo Fisher Scientific Inc.
• GeneDx
• CytoTest Inc.
• Empire Genomics
• Abbott Laboratories
• Agilent Technologies
• Biological Industries
• PerkinElmer Inc.
• Bio-RAD Laboratories Inc.
• F. Hoffmann-La Roche AG

Pre-Book Report: https://www.futuremarketinsights.com/checkout/2031

Key Segments Profiled in the Molecular Cytogenetics Industry Survey

Global Molecular Cytogenetics Market by Technique Type:

• Genomic in Situ Hybridization (GISH)
• Fluorescence in Situ Hybridization (FISH)
• Multicolour Fluorescence in Situ Hybridization
• Multiplex Fluorescence in Situ Hybridization (M-FISH)
• Spectral Karyotyping (SKY)
• Comparative Genomic Hybridization (CGH)
• Array Comparative Genomic Hybridization
• Other Molecular Cytogenetic Techniques

Global Molecular Cytogenetics Market by Product Type:

• Instruments for Molecular Cytogenetics
• Reagents & Kits for Molecular Cytogenetics

Global Molecular Cytogenetics Market by End User:

• Molecular Cytogenetics in Pharmaceutical & Biotechnology Companies
• Molecular Cytogenetics in Clinical Research Laboratories
• Molecular Cytogenetics in Research & Academic Institutes
• Molecular Cytogenetics in Hospitals
• Molecular Cytogenetics in Diagnostic Centers

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs